Clinical trial

Observational Study of Biphasic Insulin Aspart 30 Alone or in Combination With Oral Hypoglycaemic Agents in Subjects With Type 2 Diabetes

NCT01536600

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2004-09-01

PhaseN/A

Study timeline

Study start (unknown)2004-09-01Date precision: month

Registry last updated2017-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

biphasic insulin aspart 30DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01536600 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.